ABSTRACT
Purpose
To
determine the proportion of patients with chronic laryngopharyngeal disease
caused by gastroesophageal reflux and to describe the spectrum of
laryngopharyngeal alterations resulting from this pathology.
Desing
A
descriptive, prospective study of 40 adult patients with chronic
laryngopharyngeal symptoms, who underwent a paraclinical study consisting of
double sensor pH metering, videolaryngostroboscopy and digestive videoendoscopy.
Results
The
esophageal pH-metering used showed 22.5% of the patients with chronic
laryngopharyngeal disease attributable to gastroesophageal reflux, greater
prevalence was found in women; no statistical significance was found in any of
the signs and symptoms studied in these patients. A case of gastric ectopia was found as a possible diagnostic
differential and one patient was found to have laryngeal cancer.
Conclusion
No
high prevalence of the disease was found in the sample patients studied.
However, it is possible that it was not detected in some of the patients
owing to the pH-metering criterion used and the intermittent nature of the
disease.
Key
words: Gastroesophageal Reflux Disease. Gastrolaryngeal
Reflux. Inferior Esophageal Sphincter. Superior
Esophageal Sphincter. pH metering.
Correspondencia: Dr. Johnny Jiménez, Servicio de Otorrinolaringología. Hospital San Vicente de Paul. Medellín, Colombia.
BIBLIOGRAFÍA
1.
Casabuenas P, Camacho DF. La
Esofagitis Péptica por Reflujo Gastroesofágico y Endoscopia Digestiva. Revista Colombiana de Gastroenterología.
1990; 4: 227-231.
2.
Tanouye E. Battle Brews in the heartburn business as two old drugs go
over the counter. Wall street
Journal 1995.
3.
Kambic V. Radsel Z. Acid posterior laringitis, aetiology, histology,
diagnosis and treatment. J Laryngol
Otol 1984; 98: 1237-12240.
4. Koufman JA, et al. The prevalence and spectrum of reflux in laringology: a prospective study of 132 patients. Documento de Internet.
5.
Wiener GJ, Koufman JA, Wu WC, Cooper JB, Richter JE, Castell DO. Chronic
hoarseness secondary to gastrophageal reflux disease: documentation with 24-H
ambulatory pH motoring. Am J Gastroenterol 1989; 84: 150-1508.
6.
Katz PO. Ambulatory
esophageal and hypofaryngeal pH monitoring in patients with hoarseness.
Am J Gastroenterol 1990; 85: 38-40.
7.
Koufman JA: Obice Disorders. Visible obice apri 1992; 1: 2-3.
8.
Richter JE. Typical and
atypical presentation of gastroesophageal reflux desease. GI Cli North America.
1996; 25: 75-102.
9.
Cherry J, Margulis SI. Contact
ulcer of the Larynx. Laryngoscope
1968; 78: 1937-40.
10.
Steigman GV, Pearlman NW, Teter A. Upper aerodigestive manifestation of
Gastrophageal Reflux. Abstract
Gastroenterology. 1987; 92: 165-4.
11.
Morrison MD. Is chronic
gastroesophageal reflux a causative factor in glottic carcinoma? Otolaringol
Head and Neck Surg 1998; 99: 370-73.
12.
Ward PH, Hanson DG. Reflux as an aetiologic factor of carcinoma of the
laryngopharynx. Laringoscope 1998; 98:1195-99.
13.
H, Hanson DG. Reflux as an
aetiologic factor of carcinoma of the laryngopharynx.
Laryngoscope 1998; 98:
1195-99.
14.
Champion GL, Richter JE. Atypical
presentation of gastroesophageal reflux disease: Chest paint pulmonary, and ear,
nose, troat manifestations. Gastroenterology
1993; 1: 18.
15.
Jacob P, Kahrilas PJ, Herxon G, Proximal esophageal pH-metry in patients
reflux laringitis. Gastroenterology 1991; 100: 305-10.
16.
Ohman I, Olofsson J, Tibbling, et al.
Esophageal dysfunction in patients whit contact ulcer of the larynx.
Ann Otol Rhinol Laryngol 1983; 92: 228-30.
17.
Ossakow SJ, Elta G, Colturi T, et al.
Esophageal reflux and dismolity as the bass for persistent cervical
symptoms. Ann Otol Rhinol Laryngol
1984; 93: 430-7.
18.
Shaker R, Milbrand M, Ren J, Toohill R. Esophagopharyngeal distribution
of refluxed gastric acid in patients with
reflux laringitis.
Gastroenterology 1995; 109: 1575-85.
19.
Koufman JA. the Otolaryngologic manifestations or gastroesophageal reflux
disease. Laringoscope 1991; 101:
(supl 53) 1-78.
20.
Ossakow SJ, Elta G, Colturi T, et
al. Esophageal reflux and
dimotility as the basis for persistent cervical symptoms.
Ann Otol Rhinol Laryngol 1997;
96: 387-92.
21.
Koufman JA: pH monitoring in otolaryngology patients with
gastroesophageal reflux disease: Why the pharyngeal probe is esential?
(unpublished data), 1993. (Referido en Koufman JA: reflux and obice disorders).
22.
Wolfe MM, Soll AH. The phisiology of gastric secretion. NEJM 1998; 319: 1707-15.
23.
Wiener GJ, Cooper JB, Wu WC, et al: Is haornseness an atypical
manifestation of gastroesophageal reflux (GER)? An ambulatory 24 pH study.
Gastroenterology 1986; 90 A; 1691 (Abstract).
24.
Richter JE, Ambulatory esophageal pH monitoring.
American Journal of Medicine Nov 1997; 103: 130.
25.
Toohill RJ, Mustang E, Grossman TW, et al: Pharyngeal, laryngeal and
tracheobronchial manifestation of gastroesophageal reflux. Procedings
of the XXIV World Congress of Otolaryngology – Head and Neck Surgery. Berkeley
California: Kugler and Ghendini
Publishing.
26. De Mester TR, Wang CI, Wernly JA, et al. Technique, indications and clinical use of hours esophageal pH monitoring. J Torca Cardiovasc Surg 1980; 79: 656-70.
27.
Johnson LF, De Mester TR. Development
of the 24 hours intraesophageal pH monitoring composite scoring system.
J Clin Gastroenterol 1986; 9: 52-58.
28.
Richter JE, De Meester. Ambulatory Esophageal pH monitoring: Practical
Approach and clinical applications. Tokio:
Igaku-Shoin, 1991.
29. Monnier P, Ollyo JP, Fontolliet CH and Savary M.: Epidemiology and natural history of reflux exophagitis. Semin Laap Surg 1995; 2: 2-9.
30. Wiener GJ. Koufman JA. The pharingoesophageal dual ambulatory pH probe for evaluation of reflux. Gastroenterology 1987; 92: 1694.
31.
Weinstein WM, Goboch ER, Bowes KL. The
normal human esophageal mucosa histologic readparasal. Gastroenterology 1995; 68: 40.
 |
Haga su consulta por tema
